Minimal Residual Disease Status as a Surrogate Endpoint for Progression-free Survival in Newly Diagnosed Multiple Myeloma Studies: A Meta-analysis
- Resource Type
- Article
- Source
- In
Clinical Lymphoma, Myeloma and Leukemia January 2020 20(1):e30-e37 - Subject
- Language
- ISSN
- 2152-2650